Management of neutralizing antibodies against beta-IFN in beta-IFN-treated multiple sclerosis patients

被引：0
|
作者：
Andrew R. Pachner
Jennifer Brady
Israel Steiner
Kavitha Narayan
机构：
[1] University of Medicine and Dentistry of New Jersey,Dept. of Neurology and Neurosciences
[2] New Jersey Medical School,undefined
[3] Hebrew University,undefined
来源：
Journal of Neurology | 2008年 / 255卷
关键词：
Multiple Sclerosis; Multiple Sclerosis Patient; Mitoxantrone; Rebif; Avonex;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Management of neutralizing antibodies against beta-IFN in beta-IFN-treated multiple sclerosis patients
    Pachner, Andrew R.
    Brady, Jennifer
    Steiner, Israel
    Narayan, Kavitha
    [J]. JOURNAL OF NEUROLOGY, 2008, 255 (11) : 1815 - 1817
  • [2] Fate of neutralizing and binding antibodies to IFN beta in MS patients treated with IFN beta for 6 years
    Bellomi, F
    Scagnolari, C
    Tomassini, V
    Gasperini, C
    Paolillo, A
    Pozzilli, C
    Antonelli, G
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 215 (1-2) : 3 - 8
  • [3] Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b
    Antonelli, G
    Simeoni, E
    Bagnato, F
    Pozzilli, C
    Turriziani, O
    Tesoro, R
    Di Marco, P
    Gasperini, C
    Fieschi, C
    Dianzani, F
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 168 (02) : 131 - 136
  • [4] IMMUNOMODULATORY ACTIVITIES OF BETA-IFN
    LIBERATI, AM
    BISCOTTINI, B
    ALLEGRA, A
    CARINI, S
    PECCI, A
    SBARRETTI, R
    PUXEDDU, A
    [J]. INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1985, 7 (04): : 616 - 616
  • [5] Neutralizing antibodies against IFN beta in patients with multiple sclerosis: A comparative study of two cytopathic effect tests (CPE) for their detection
    Oliver, B.
    Orpez, T.
    Mayorga, C.
    Pinto-Medel, M. J.
    Leyva, L.
    Lopez-Gomez, C.
    Marin, C.
    Luque, G.
    Ortega-Pinazo, J.
    Fernandez, O.
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2009, 351 (1-2) : 41 - 45
  • [6] Management of patients with neutralizing antibodies against interferon-beta: stop IFN-beta therapy or wait for the antibodies to go away?
    Sorensen, P. S.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (01) : 1 - 2
  • [7] Neutralizing and binding antibodies to different IFN-β molecules in multiple sclerosis patients treated with natural IFN-β.
    Mayorga, C
    Luque, G
    Guerrero, R
    Blanca, M
    Fernández, O
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S20 - S21
  • [8] Early benefits of neutralizing antibodies against IFN-β in multiple sclerosis
    [J]. Nature Clinical Practice Neurology, 2007, 3 (5): : 246 - 247
  • [9] The significance of neutralizing antibodies in patients with multiple sclerosis treated with interferon beta
    Rice, G
    [J]. ARCHIVES OF NEUROLOGY, 2001, 58 (08) : 1297 - 1298
  • [10] IFN-beta biological activity for the management of multiple sclerosis patients
    Hillert, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 636 - 636
12345